Hem › Lymfom › Utah › Salt Lake City
Kliniska studier för Lymfom i Salt Lake City, UT
11 studier för Lymfom söker deltagare vid platser i och runt Salt Lake City (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
RekryterarFas 1/2
- Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
Rekryterar
- Huntsman Cancer Institute, Salt Lake City
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekryterarFas 2
- University of Utah, Salt Lake City
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
RekryterarFas 1/2
- Primary Children's Hospital, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekryterarFas 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekryterarFas 3
- Intermountain Healthcare, Salt Lake City
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekryterarObservationsstudie
- Huntsman Cancer Institute, University of Utah, Salt Lake City
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekryterarFas 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
Rekryterar
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
RekryterarFas 1/2
- University of Utah, Salt Lake City
Lymfom-studier i andra städer
- Houston, TX34 studier
- Boston, MA33 studier
- New York City, NY33 studier
- Washington, DC23 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- Durham, NC17 studier
- St. Louis, MO15 studier
- Philadelphia, PA15 studier
- Cleveland, OH14 studier
- Edison, NJ12 studier
- Atlanta, GA12 studier
Andra studier i Salt Lake City
- Icke-småcellig lungcancer31 studier
- Cancer (alla typer)27 studier
- Bröstcancer27 studier
- Kolorektal cancer22 studier
- Lungcancer21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastaserande cancer20 studier
- Äggstockscancer19 studier
- Övervikt18 studier
- Akut myeloid leukemi17 studier
- Hjärtsvikt17 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.